APYX (Apyx Medical) Total Liabilities: $49.98 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APYX Apyx Medical Corp APYX
72 GF Score
Price $3.06
GF Value $2.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Apyx Medical Total Liabilities?

Apyx Medical APYX +0.99% 72 Total Liabilities is $49.98 Mil as of Jun. 2026. GuruFocus rates APYX with a GF Score™ of 72/100 and a GF Value™ of $2.21 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Apyx Medical's Total Liabilities for the quarter that ended in Jun. 2026 was $49.98 Mil.

Apyx Medical's quarterly Total Liabilities declined from Dec. 2025 ($52.01 Mil) to Mar. 2026 ($49.94 Mil) but then increased from Mar. 2026 ($49.94 Mil) to Jun. 2026 ($49.98 Mil).

Apyx Medical's annual Total Liabilities declined from Dec. 2023 ($52.32 Mil) to Dec. 2024 ($50.51 Mil) but then increased from Dec. 2024 ($50.51 Mil) to Dec. 2025 ($52.01 Mil).

Apyx Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for Apyx Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical Total Liabilities Chart

Apyx Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.71 13.98 52.32 50.51 52.01

Apyx Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.73 51.29 52.01 49.94 49.98
APYX
72GF Score
Apyx Medical Corp APYX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apyx Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Apyx Medical's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.7+(38.912+0.347
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1.05+0+0)
=52.01

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=66.84-14.831
=52.01

Apyx Medical's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.354+(39.158+0.336
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1.134+0+0)
=49.98

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=61.072-11.09
=49.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $49.98 Mil mean?
Apyx Medical (APYX) has a Total Liabilities of $49.98 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Apyx Medical and its competitors.
Is Apyx Medical's Total Liabilities too high?
Apyx Medical's current Total Liabilities is $49.98 Mil. Overall, Apyx Medical has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Apyx Medical's Total Liabilities compare to INGN and QSI?
Apyx Medical's Total Liabilities of $49.98 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Apyx Medical and its competitors. Apyx Medical's current Total Liabilities is $49.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apyx Medical stock overvalued right now?
Based on GuruFocus' analysis, Apyx Medical (APYX) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.21, compared to a current price of $3.06 — trading 38.5% above its estimated fair value. The current Total Liabilities is $49.98 Mil. Apyx Medical's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Apyx Medical (APYX), the current Total Liabilities is $49.98 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apyx Medical (APYX) Overvalued in 2026?

Based on GuruFocus' analysis, Apyx Medical stock appears to be overvalued. The current stock price of $3.06 is trading 38.5% above its estimated GF Value™ of $2.21. GuruFocus considers Apyx Medical to be Significantly Overvalued.

Key valuation signals for APYX:

  • Total Liabilities: $49.98 Mil
  • GF Value™: $2.21 vs. price of $3.06 (38.5% above fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the APYX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apyx Medical Business Description

Other Exchanges BOV:Germany
Address 5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
72GF Score

Get the complete analysis for APYX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.06
Price
$2.21
GF Value